Company Statement: ViroPharma discloses FTC probe into Vancocin
MLex Summary: ViroPharma said it had received a notice from the US Federal Trade Commission that the agency had opened an investigation into whether the company engaged in unfair methods of...To view the full article, register now.
Already a subscriber? Click here to view full article